290 related articles for article (PubMed ID: 20214904)
1. Functional interaction of human neutrophil peptide-1 with the cell wall precursor lipid II.
de Leeuw E; Li C; Zeng P; Li C; Diepeveen-de Buin M; Lu WY; Breukink E; Lu W
FEBS Lett; 2010 Apr; 584(8):1543-8. PubMed ID: 20214904
[TBL] [Abstract][Full Text] [Related]
2. Structural Insights into the Mode of Action of the Peptide Antibiotic Copsin.
Franzoi M; van Heuvel Y; Thomann S; Schürch N; Kallio PT; Venier P; Essig A
Biochemistry; 2017 Sep; 56(37):4992-5001. PubMed ID: 28825809
[TBL] [Abstract][Full Text] [Related]
3. Insight into invertebrate defensin mechanism of action: oyster defensins inhibit peptidoglycan biosynthesis by binding to lipid II.
Schmitt P; Wilmes M; Pugnière M; Aumelas A; Bachère E; Sahl HG; Schneider T; Destoumieux-Garzón D
J Biol Chem; 2010 Sep; 285(38):29208-16. PubMed ID: 20605792
[TBL] [Abstract][Full Text] [Related]
4. Plectasin, a fungal defensin, targets the bacterial cell wall precursor Lipid II.
Schneider T; Kruse T; Wimmer R; Wiedemann I; Sass V; Pag U; Jansen A; Nielsen AK; Mygind PH; Raventós DS; Neve S; Ravn B; Bonvin AM; De Maria L; Andersen AS; Gammelgaard LK; Sahl HG; Kristensen HH
Science; 2010 May; 328(5982):1168-72. PubMed ID: 20508130
[TBL] [Abstract][Full Text] [Related]
5. Impact of pro segments on the folding and function of human neutrophil alpha-defensins.
Wu Z; Li X; Ericksen B; de Leeuw E; Zou G; Zeng P; Xie C; Li C; Lubkowski J; Lu WY; Lu W
J Mol Biol; 2007 Apr; 368(2):537-49. PubMed ID: 17355880
[TBL] [Abstract][Full Text] [Related]
6. Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II.
Lunde CS; Hartouni SR; Janc JW; Mammen M; Humphrey PP; Benton BM
Antimicrob Agents Chemother; 2009 Aug; 53(8):3375-83. PubMed ID: 19470513
[TBL] [Abstract][Full Text] [Related]
7. Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides.
Münch D; Sahl HG
Biochim Biophys Acta; 2015 Nov; 1848(11 Pt B):3062-71. PubMed ID: 25934055
[TBL] [Abstract][Full Text] [Related]
8. An intimate link between antimicrobial peptide sequence diversity and binding to essential components of bacterial membranes.
Schmitt P; Rosa RD; Destoumieux-Garzón D
Biochim Biophys Acta; 2016 May; 1858(5):958-70. PubMed ID: 26498397
[TBL] [Abstract][Full Text] [Related]
9. Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.
Sass V; Schneider T; Wilmes M; Körner C; Tossi A; Novikova N; Shamova O; Sahl HG
Infect Immun; 2010 Jun; 78(6):2793-800. PubMed ID: 20385753
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dynamics Simulations Reveal the Conformational Flexibility of Lipid II and Its Loose Association with the Defensin Plectasin in the Staphylococcus aureus Membrane.
Witzke S; Petersen M; Carpenter TS; Khalid S
Biochemistry; 2016 Jun; 55(23):3303-14. PubMed ID: 27158738
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.
Peschel A; Jack RW; Otto M; Collins LV; Staubitz P; Nicholson G; Kalbacher H; Nieuwenhuizen WF; Jung G; Tarkowski A; van Kessel KP; van Strijp JA
J Exp Med; 2001 May; 193(9):1067-76. PubMed ID: 11342591
[TBL] [Abstract][Full Text] [Related]
12. The mode of action of the lantibiotic lacticin 3147--a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II.
Wiedemann I; Böttiger T; Bonelli RR; Wiese A; Hagge SO; Gutsmann T; Seydel U; Deegan L; Hill C; Ross P; Sahl HG
Mol Microbiol; 2006 Jul; 61(2):285-96. PubMed ID: 16771847
[TBL] [Abstract][Full Text] [Related]
13. The cell wall precursor lipid II acts as a molecular signal for the Ser/Thr kinase PknB of Staphylococcus aureus.
Hardt P; Engels I; Rausch M; Gajdiss M; Ulm H; Sass P; Ohlsen K; Sahl HG; Bierbaum G; Schneider T; Grein F
Int J Med Microbiol; 2017 Jan; 307(1):1-10. PubMed ID: 27989665
[TBL] [Abstract][Full Text] [Related]
14. Total Synthesis of Laspartomycin C and Characterization of Its Antibacterial Mechanism of Action.
Kleijn LH; Oppedijk SF; 't Hart P; van Harten RM; Martin-Visscher LA; Kemmink J; Breukink E; Martin NI
J Med Chem; 2016 Apr; 59(7):3569-74. PubMed ID: 26967152
[TBL] [Abstract][Full Text] [Related]
15. Systematic mutational analysis of human neutrophil α-defensin HNP4.
Hu H; Di B; Tolbert WD; Gohain N; Yuan W; Gao P; Ma B; He Q; Pazgier M; Zhao L; Lu W
Biochim Biophys Acta Biomembr; 2019 Apr; 1861(4):835-844. PubMed ID: 30658057
[TBL] [Abstract][Full Text] [Related]
16. Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides.
Grein F; Schneider T; Sahl HG
J Mol Biol; 2019 Aug; 431(18):3520-3530. PubMed ID: 31100388
[TBL] [Abstract][Full Text] [Related]
17. Eurocin, a new fungal defensin: structure, lipid binding, and its mode of action.
Oeemig JS; Lynggaard C; Knudsen DH; Hansen FT; Nørgaard KD; Schneider T; Vad BS; Sandvang DH; Nielsen LA; Neve S; Kristensen HH; Sahl HG; Otzen DE; Wimmer R
J Biol Chem; 2012 Dec; 287(50):42361-72. PubMed ID: 23093408
[TBL] [Abstract][Full Text] [Related]
18. Targeting bactoprenol-coupled cell envelope precursors.
Ulm H; Schneider T
Appl Microbiol Biotechnol; 2016 Sep; 100(18):7815-25. PubMed ID: 27495122
[TBL] [Abstract][Full Text] [Related]
19. Turning defense into offense: defensin mimetics as novel antibiotics targeting lipid II.
Varney KM; Bonvin AM; Pazgier M; Malin J; Yu W; Ateh E; Oashi T; Lu W; Huang J; Diepeveen-de Buin M; Bryant J; Breukink E; Mackerell AD; de Leeuw EP
PLoS Pathog; 2013; 9(11):e1003732. PubMed ID: 24244161
[TBL] [Abstract][Full Text] [Related]
20. Staphylococcus aureus resists human defensins by production of staphylokinase, a novel bacterial evasion mechanism.
Jin T; Bokarewa M; Foster T; Mitchell J; Higgins J; Tarkowski A
J Immunol; 2004 Jan; 172(2):1169-76. PubMed ID: 14707093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
